1. Home
  2. UAMY vs MOLN Comparison

UAMY vs MOLN Comparison

Compare UAMY & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UAMY
  • MOLN
  • Stock Information
  • Founded
  • UAMY 1968
  • MOLN 2004
  • Country
  • UAMY United States
  • MOLN Switzerland
  • Employees
  • UAMY N/A
  • MOLN N/A
  • Industry
  • UAMY Metal Fabrications
  • MOLN
  • Sector
  • UAMY Industrials
  • MOLN
  • Exchange
  • UAMY Nasdaq
  • MOLN Nasdaq
  • Market Cap
  • UAMY 251.9M
  • MOLN 183.2M
  • IPO Year
  • UAMY N/A
  • MOLN 2021
  • Fundamental
  • Price
  • UAMY $3.56
  • MOLN $4.14
  • Analyst Decision
  • UAMY Strong Buy
  • MOLN
  • Analyst Count
  • UAMY 4
  • MOLN 0
  • Target Price
  • UAMY $2.90
  • MOLN N/A
  • AVG Volume (30 Days)
  • UAMY 5.0M
  • MOLN 25.6K
  • Earning Date
  • UAMY 05-08-2025
  • MOLN 03-06-2025
  • Dividend Yield
  • UAMY N/A
  • MOLN N/A
  • EPS Growth
  • UAMY N/A
  • MOLN N/A
  • EPS
  • UAMY N/A
  • MOLN N/A
  • Revenue
  • UAMY $18,865,900.00
  • MOLN $5,484,562.00
  • Revenue This Year
  • UAMY $269.08
  • MOLN N/A
  • Revenue Next Year
  • UAMY $119.31
  • MOLN $866.67
  • P/E Ratio
  • UAMY N/A
  • MOLN N/A
  • Revenue Growth
  • UAMY 97.46
  • MOLN N/A
  • 52 Week Low
  • UAMY $0.21
  • MOLN $3.36
  • 52 Week High
  • UAMY $3.86
  • MOLN $12.70
  • Technical
  • Relative Strength Index (RSI)
  • UAMY 61.91
  • MOLN 55.33
  • Support Level
  • UAMY $3.23
  • MOLN $3.79
  • Resistance Level
  • UAMY $3.59
  • MOLN $4.27
  • Average True Range (ATR)
  • UAMY 0.31
  • MOLN 0.28
  • MACD
  • UAMY -0.01
  • MOLN 0.06
  • Stochastic Oscillator
  • UAMY 67.89
  • MOLN 76.79

About UAMY United States Antimony Corporation

United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has four operating segments: United States Antimony, Mexican antimony, zeolite, and Precious metals. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Share on Social Networks: